Abstract
Purpose
Because superparamagnetic iron oxide is actively taken into the reticuloendothelial system, the signal intensity observed on T2-weighted images is reduced not only in the liver but also in the spleen. There is no difference in the reduction in signal intensity in the liver after contrast between the ferumoxides and ferucarbotran, but the reduction in signal intensity in the spleen is considerable. In the present study, we examined the efficacy of T2*-weighted imaging to compensate for the reduction in signal intensity in the spleen by administering ferucarbotran.
Materials and methods
We examined the images obtained from 35 patients who underwent MRI with ferucarbotran. T2-weighted images and T2*-weighted images were obtained before and after administration of ferucarbotran, and the changes in signal intensity in the liver and spleen were then analyzed.
Results
A reduction in signal intensity was observed in the liver by both T2- and T2*-weighted imaging. In the spleen, the signal intensity was reduced on T2-weighted images but was not reduced on T2*-weighted images.
Conclusion
The reduction in signal intensity due to administration of ferucarbotran is low in the spleen. Thus, it was considered necessary to approach the problem of diagnosing ectopic splenic tissue using ferucarbotran with caution.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
DD Stark R Weissleder G Elizondo PF Hahn S Saini LE Todd et al. (1988) ArticleTitleSuperparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver Radiology 168 297–301 Occurrence Handle3393649 Occurrence Handle1:STN:280:DyaL1c3nslWktg%3D%3D
G Marchal P Van Hecke P Demaerel E Decrop C Kennis AL Baert et al. (1989) ArticleTitleDetection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T AJR Am J Roentgenol 152 771–5 Occurrence Handle2784260 Occurrence Handle1:STN:280:DyaL1M7msVSlug%3D%3D
PR Ros PC Freeny SE Harms SE Seltzer PL Davis TW Chan et al. (1995) ArticleTitleHepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions Radiology 196 481–8 Occurrence Handle7617864 Occurrence Handle1:STN:280:DyaK2MzktlWitw%3D%3D
F Chen J Ward PJ Robinson (1999) ArticleTitleMR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents Magn Reson Imaging 17 549–56 Occurrence Handle10231181 Occurrence Handle10.1016/S0730-725X(98)00193-3 Occurrence Handle1:STN:280:DyaK1M3ks1aisA%3D%3D
SD Vuysere WV Steebergen R Aerts HV Hauwaert DV Beckevoort LV Hoe (2000) ArticleTitleIntrahepatic splenosis: imaging features Abdom Imaging 25 187–9 Occurrence Handle10675464 Occurrence Handle10.1007/s002619910042
AJ Berman MP Zahalsky SA Okon JR Wagner (2003) ArticleTitleDistinguishing splenosis from renal masses using ferumoxide-enhanced magnetic resonance imaging Urology 62 748x–xii Occurrence Handle10.1016/S0090-4295(03)00509-0
SH Kim JM Lee JK Han JY Lee WJ Kang JY Jang et al. (2006) ArticleTitleMDCT and superparamagnetic iron oxide (SPIO)-enhanced MR findings of intrapancreatic accessory spleen in seven patients Eur Radiol 16 1887–97 Occurrence Handle16547707 Occurrence Handle10.1007/s00330-006-0193-6
KA Miles SJ McPherson MP Hayball (1995) ArticleTitleTransient splenic inhomogeneity with contrast-enhanced CT: mechanism and effect of liver disease Radiology 194 91–5 Occurrence Handle7997588 Occurrence Handle1:STN:280:DyaK2M%2FptVWntQ%3D%3D
A Tanimoto K Oshio M Suematsu D Pouliquen DD Stark (2001) ArticleTitleRelaxation effects of clustered particles J Magn Reson Imaging 14 72–7 Occurrence Handle11436217 Occurrence Handle10.1002/jmri.1153 Occurrence Handle1:STN:280:DC%2BD3MznvFajtw%3D%3D
SH Kim D Choi JH Lim WJ Lee HJ Jang Lim Hk et al. (2002) ArticleTitleOptimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences Korean J Radiol 3 87–97 Occurrence Handle12087198 Occurrence Handle10.3348/kjr.2002.3.2.87
JH Kim MJ Kim SH Suh JJ Chung HS Yoo JT Lee (2002) ArticleTitleCharacterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times J Magn Reson Imaging 15 573–83 Occurrence Handle11997899 Occurrence Handle10.1002/jmri.10102
S Kumano T Murakami T Kim M Hori A Okada T Sugiura et al. (2003) ArticleTitleUsing superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions AJR Am J Roentgenol 181 1335–9 Occurrence Handle14573430
T Takahara Y Imai T Yamashita S Yasuda S Nasu MV Cauteren (2004) ArticleTitleDiffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display Radiat Med 22 275–82 Occurrence Handle15468951
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Gomi, T., Nagamoto, M., Tsunoo, M. et al. Evaluation of the changes in signals from the spleen using ferucarbotran. Radiat Med 25, 135–138 (2007). https://doi.org/10.1007/s11604-006-0108-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-006-0108-0